1. Session II, Slide 1 Progestin-Only Injectable Contraceptives Session II: Who Can and Cannot Use Progestin-Only Injectables

2. Session II, Slide 2 Progestin-Only Injectables Are Safe For Most Women Almost all women can use progestin-only injectables safely, including women who: –Have or have not had children –Cannot do or do not want to use other methods –Are breastfeeding a baby who is at least 6 weeks old (WHO/MEC) –Smoke (regardless of age or number of cigarettes) –Have an STI, HIV or AIDS –Just had a miscarriage or abortion –Are taking medicines, including ARVs to treat AIDS Most health conditions do not affect safe and effective use of injectables Source: CCP and WHO, 2011

3. Session I, Slide # 3 Source: WHO, 2010. Had a heart attack or stroke or has blood clots Has breast cancer Has serious liver disease I cannot eat sweets. Has diabetes Has very high blood pressure Hmm… that is high. Who Should Not Use Injectables (part 1)

4. Session II, Slide 4 Who Should Not Use Injectables (part 2) Source: WHO, 2010. Is pregnant Thinks she may be pregnant My period is late… Is breastfeeding a baby less than six weeks old (WHO/MEC) Has abnormal vaginal bleeding Has systemic lupus

5. Session II, Slide 5 What are medical eligibility criteria? Define the categories. Review the job aid. Medical Eligibility Criteria

6. Session II, Slide 6 WHO’s Medical Eligibility Criteria Categories for IUDs, Hormonal and Barrier Methods CategoryDescription When clinical judgment is available 1No restriction for use Use the method under any circumstances 2 Benefits generally outweigh risks Generally use the method 3 Risks usually outweigh benefits Use of method not usually recommended, unless other methods are not available/acceptable 4Unacceptable health riskMethod not to be used Source: WHO, 2010.

7. Session II, Slide 7 WHO’s Medical Eligibility Criteria Categories for IUDs, Hormonal and Barrier Methods Source: WHO, 2010. Category When clinical judgment is limited 1 Use the method (Yes) 2 3 Do not use the method (No) 4

8. Session II, Slide # 8 Category 1 Examples (not inclusive): Who Can Use DMPA or NET-EN WHO CategoryConditions (selected examples) Category 1 Age 18-45 years; any parity (including nulliparous); smoking (any amount, any age); breastfeeding after 6 weeks postpartum; postabortion; and acute or chronic hepatitis. NET-ET: Obesity of more than 30 kg/m2 body mass index in women younger than 18 ears of age. DMPA: Women who are using certain types of ARVs (non-nucleoside reverse transcriptase inhibitors or ritonavir-boosted protease inhibitors). DMPA: Women using specific anticonvulsants (phenytoin, carbamazepine, barbiturates, primidone topiramate, or oxcarbazepine). Source: WHO, 2010.

9. Session II, Slide # 9 Category 2 Examples (not inclusive): Who Can Use DMPA or NET-EN WHO CategoryConditions (selected examples) Category 2 Age 45; mild hypertension (BP <159/99 mmHg); non-vascular diabetes; prolonged or heavy bleeding patterns; and history of DVT. DMPA: Obesity of more than 30 kg/m2 body mass index in women younger than 18 ears of age. NET-EN: Women who are using certain types of ARVs (non-nucleoside reverse transcriptase inhibitors or ritonavir-boosted protease inhibitors). NET-EN: Women using specific anticonvulsants (phenytoin, carbamazepine, barbiturates, primidone topiramate, or oxcarbazepine). Source: WHO, 2010.

10. Session II, Slide # 10 Category 3 and 4 Examples (not inclusive): Who Should Not Use DMPA and NET-EN WHO CategoryConditions (selected examples) Category 3 Breastfeeding before 6 weeks postpartum, severe hypertension (≥160/≥100 mmHg), unexplained vaginal bleeding (before evaluation) acute DVT/PE, complicated diabetes, severe liver disease Category 4Current breast cancer Source: WHO, 2010.

11. Session II, Slide # 11 Injectables Use by Women with HIV and AIDS Women with HIV or AIDS can use without restrictions Injectable dose provides wide margin of effectiveness Return for injections on time if on any type of ARV treatment Encourage dual method use WHO Eligibility Criteria ConditionCategory HIV-infected 1 AIDS 1 ARV therapy 1 or 2 Source: WHO, 2010; Nanda, 2008; Cohn, 2007

12. Session II, Slide # 12 Injectables Use by Postpartum Women Non-breastfeeding women can initiate immediately postpartum Breastfeeding women –Generally should not use injectables before 6 weeks postpartum –No restrictions after 6 weeks postpartum Source: WHO, 2010. WHO Eligibility Criteria Characteristic/ Condition Category Non- breastfeeding 1 Breastfeeding <6 weeks 3 Breastfeeding ≥6 weeks 1

13. Session II, Slide # 13 Understanding the Injectables Checklist Read questions 1–9 in the checklist and match them with the conditions and categories on the MEC quick reference chart. This set of questions identifies women who should not use injectables. The checklist also gives instructions about initiating injectables. This set of questions identifies women who are not pregnant.